PMID- 30237284 OWN - NLM STAT- MEDLINE DCOM- 20181106 LR - 20190409 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 115 IP - 41 DP - 2018 Oct 9 TI - Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia. PG - E9668-E9677 LID - 10.1073/pnas.1803384115 [doi] AB - Progesterone (P4) is a potent neuroprotectant and a promising therapeutic for stroke treatment. However, the underlying mechanism(s) remain unclear. Our laboratory recently reported that brain-derived neurotrophic factor (BDNF) is a critical mediator of P4's protective actions and that P4-induced BDNF release from cortical astrocytes is mediated by a membrane-associated progesterone receptor, Pgrmc1. Here, we report that the microRNA (miRNA) let-7i is a negative regulator of Pgrmc1 and BDNF in glia and that let-7i disrupts P4-induced BDNF release and P4's beneficial effects on cell viability and markers of synaptogenesis. Using an in vivo model of ischemia, we demonstrate that inhibiting let-7i enhances P4-induced neuroprotection and facilitates functional recovery following stroke. The discovery of such factors that regulate the cytoprotective effects of P4 may lead to the development of biomarkers to differentiate/predict those likely to respond favorably to P4 versus those that do not. FAU - Nguyen, Trinh AU - Nguyen T AD - Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107. AD - Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX 76107. FAU - Su, Chang AU - Su C AD - Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107. AD - Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX 76107. FAU - Singh, Meharvan AU - Singh M AUID- ORCID: 0000-0002-8072-1769 AD - Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107; Meharvan.Singh@unthsc.edu. AD - Institute for Healthy Aging, University of North Texas Health Science Center, Fort Worth, TX 76107. LA - eng GR - P01 AG027956/AG/NIA NIH HHS/United States GR - T32 AG020494/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20180920 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Membrane Proteins) RN - 0 (MicroRNAs) RN - 0 (Neuroprotective Agents) RN - 0 (PGRMC1 protein, mouse) RN - 0 (Receptors, Progesterone) RN - 0 (mirnlet7 microRNA, mouse) RN - 4G7DS2Q64Y (Progesterone) SB - IM MH - Animals MH - Astrocytes/metabolism/pathology MH - Brain Ischemia/drug therapy/*metabolism/pathology MH - Brain-Derived Neurotrophic Factor/metabolism MH - Cerebral Cortex/*metabolism/pathology MH - Disease Models, Animal MH - Membrane Proteins/metabolism MH - Mice MH - MicroRNAs/*antagonists & inhibitors/metabolism MH - Neuroprotective Agents/*pharmacology MH - Progesterone/*pharmacology MH - Receptors, Progesterone/metabolism MH - Recovery of Function/*drug effects PMC - PMC6187141 OTO - NOTNLM OT - BDNF OT - Pgrmc1 OT - ischemic stroke OT - let-7i OT - progesterone COIS- Conflict of interest statement: The authors of this manuscript are coinventors on a patent application (application no. PCT/US18/46456). EDAT- 2018/09/22 06:00 MHDA- 2018/11/07 06:00 PMCR- 2019/04/09 CRDT- 2018/09/22 06:00 PHST- 2018/09/22 06:00 [pubmed] PHST- 2018/11/07 06:00 [medline] PHST- 2018/09/22 06:00 [entrez] PHST- 2019/04/09 00:00 [pmc-release] AID - 1803384115 [pii] AID - 201803384 [pii] AID - 10.1073/pnas.1803384115 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9668-E9677. doi: 10.1073/pnas.1803384115. Epub 2018 Sep 20.